Inovio Pharmaceuticals, Inc.

NASDAQ:INO

Biotechnology

Healthcare
$1.71 -0.90%

-$0.01 today

Market cap
$118.15M
Beta
1.49
P/E (TTM)
-8.9
EPS (TTM)
-$0.12
52W Low $1.03High $2.98

Volume 9.92M

Average 2.73M

Income Statement

Follow revenue through to earnings.

Revenue

$65,343.00

FY 2025 · Annual

-70.0% YoY

Operating Income

-$86.82M

FY 2025 · Annual

Net Income

-$84.95M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.77M10.26M832.01K217.76K65.34K
Cost of Revenue00000
Gross Profit1.77M10.26M832.01K217.76K65.34K
Gross Margin100.0%100.0%100.0%100.0%100.0%
Research & Development249.24M187.65M86.68M75.62M54.21M
Selling, General & Admin53.75M90.19M47.58M37M32.68M
Operating Expenses302.99M277.84M144.77M112.62M86.89M
Depreciation & Amortization4.73M5.5M3.5M3.13M2.99M
EBITDA(296.56M)(270.9M)(130.39M)(103.95M)(81.96M)
EBITDA Margin-16709.7%-2639.8%-15671.8%-47735.2%-125425.9%
Operating Income(301.22M)(267.57M)(143.94M)(112.4M)(86.82M)
Operating Margin-16972.3%-2607.4%-17300.3%-51616.9%-132871.3%
Interest Income3.36M4.78M8.13M4.77M2.42M
Interest Expense1.94M1.25M1.22M177.83K0
Other Income / Expenses(2.44M)(12.24M)8.82M5.14M1.88M
Income Before Tax(303.66M)(279.82M)(135.12M)(107.25M)(84.95M)
Pre-Tax Margin-17109.9%-2726.7%-16239.9%-49254.3%-130000.0%
Income Tax Expense00000
Net Income(303.66M)(279.82M)(135.12M)(107.25M)(84.95M)
Net Margin-17109.9%-2726.7%-16239.9%-49254.3%-130000.0%
EPS (Basic)(1.42)(14.07)(6.09)(3.95)(1.81)
EPS (Diluted)(1.42)(14.07)(6.09)(3.95)(1.81)
Weighted Avg Shares214.62M19.89M22.17M27.16M468.86M
Weighted Avg Shares (Diluted)214.62M19.89M22.17M27.16M468.86M

INO Earnings Waterfall · TTM

NASDAQ:INO · Revenue to Net Income

Key Ratios

EPS$-1.71
Gross Margin0.0%
Net Margin0.0%
P/E Ratio9.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$84.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.71, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
FWPFWP filingNov 6, 2026
424B5424B5 filingNov 6, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
424B5424B5 filingNov 5, 2026

How much revenue does INO generate?

Inovio Pharmaceuticals, Inc. (INO) reported $65,343.00 of revenue in fiscal 2025.

Is INO profitable?

Inovio Pharmaceuticals, Inc. (INO) reported -$84.95M of net income, with a net margin of -130000.0%.